Carmona-Bozo, Julia C.
Manavaki, Roido
Miller, Jodi L.
Brodie, Cara
Caracò, Corradina
Woitek, Ramona
Baxter, Gabrielle C.
Graves, Martin J.
Fryer, Tim D.
Provenzano, Elena
Gilbert, Fiona J. http://orcid.org/0000-0002-0124-9962
Funding for this research was provided by:
Cancer Research UK Cambridge Institute, University of Cambridge (C197/A16465)
Article History
Received: 16 December 2022
Revised: 16 December 2022
Accepted: 8 February 2023
First Online: 11 May 2023
Declarations
:
: The scientific guarantor of this publication is Professor Fiona J. Gilbert.
: The authors declare relationships with the following companies: GE Healthcare.
: No complex statistical methods were necessary for this paper.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained. All procedures performed involving human participants were in accordance with the ethical standards of a National Research Ethics Committee (NRES Committee East of England – Cambridge Central; 14/EE/0145) and the Administration of Radioactive Substances Advisory Committee (ARSAC), UK.
: Some study subjects have been previously reported in Carmona-Bozo JC, Manavaki R, Woitek R, et al (2021) Hypoxia and perfusion in breast cancer: simultaneous assessment using PET/MR imaging. Eur Radiol 31:333-44.
: • prospective• observational• performed at one institution